Skip to main content
Internal Medicine
ALL Specialities
ALL Specialities
/
Internal Medicine
CME
COVID-19 Updates
Diseases & Conditions
Asthma
Diabetes
Musculoskeletal Disorders
Obesity
Pain
Rare Diseases
Subspecialties
Addiction Medicine
Adolescent Medicine
Cardiology
Critical Care
Dermatology
Endocrinology
Gastroenterology
Geriatrics
Hematology
Hepatology
Hospice & Palliative Medicine
Immunology
Infectious Diseases
Men's Health
Mental Health
Nephrology
Neurology
Oncology
Pulmonology
Rheumatology
Sleep Medicine
Transgender Health
Women's Health
Multimedia
Audio
Podcasts
Video
Business of Medicine
Conference Coverage
Joint European atrial fibrillation guidelines break new ground
Publish date:
October 24, 2016
bjancin@frontlinemedcom.com
Pages
« first
1
2
Recommended Reading
Solid INRs on warfarin don’t predict future stability
MDedge Internal Medicine
VIDEO: NOACs cut intracranial bleeds in real-world atrial fib patients
MDedge Internal Medicine
Andexanet controlled factor Xa inhibitor–related bleeding
MDedge Internal Medicine
VIDEO: ICDs cut mortality in younger, healthier heart failure patients
MDedge Internal Medicine
ENSURE-AF trial supports edoxaban for electrical cardioversion
MDedge Internal Medicine
Commentary: INR instability in the NOAC era
MDedge Internal Medicine
Trials offer lessons despite negative primary endpoints
MDedge Internal Medicine
Rivaroxaban linked to more bleeding compared with dabigatran in elderly patients with nonvalvular AF
MDedge Internal Medicine
FDA reaffirms rivaroxaban’s atrial fib efficacy in ROCKET AF
MDedge Internal Medicine
Beta-blockers curb death risk in patients with primary prevention ICD
MDedge Internal Medicine
Cardiology
All Specialties
